Utility of 24-hour ambulatory monitoring and the Sflt-1/PlGF ratio in preeclampsia prediction

Hypertens Res. 2024 May;47(5):1436-1437. doi: 10.1038/s41440-024-01600-2. Epub 2024 Feb 21.

Authors

Walter Espeche^{1

2}, Julian Minetto^{3

4}, Martin R Salazar^{1

2}

Affiliations

¹ Faculty of Medical Sciences, National University of La Plata, La Plata, Argentina.
² San Martin General Acute Care Interzonal Hospital, La Plata, Argentina.
³ Faculty of Medical Sciences, National University of La Plata, La Plata, Argentina. jjminetto@hotmail.com.
⁴ San Martin General Acute Care Interzonal Hospital, La Plata, Argentina. jjminetto@hotmail.com.

PMID: 38383891
DOI: 10.1038/s41440-024-01600-2

No abstract available

Keywords: Ambulatory blood pressure; Hypertension pregnancy; Preeclampsia.

Publication types

Letter

MeSH terms

Adult
Biomarkers / blood
Blood Pressure Monitoring, Ambulatory
Female
Humans
Placenta Growth Factor* / blood
Pre-Eclampsia* / blood
Pre-Eclampsia* / diagnosis
Predictive Value of Tests
Pregnancy
Vascular Endothelial Growth Factor Receptor-1* / blood

Substances

Vascular Endothelial Growth Factor Receptor-1
FLT1 protein, human
Placenta Growth Factor
PGF protein, human
Biomarkers